Precision medicine and personalized breast cancer: combination pertuzumab therapy
Kerry Reynolds, Sasmit Sarangi, Aditya Bardia, Don S Dizon Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA Abstract: Trastuzumab (Herceptin), a monoclonal antibody directed against the human epidermal growth-factor receptor 2 (HER2), is the poster child for an...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-03-01
|
| Series: | Pharmacogenomics and Personalized Medicine |
| Online Access: | http://www.dovepress.com/precision-medicine-and-personalized-breast-cancer-combination-pertuzum-a16169 |